ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Targeted Chemotherapy Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-22H16787
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Targeted Chemotherapy Drugs Market Research Report 2024
BUY CHAPTERS

Global Targeted Chemotherapy Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-22H16787
Report
November 2025
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Celgene
Bristol–Myers Squibb
Takeda
Seekyo

Targeted Chemotherapy Drugs Market

The global Targeted Chemotherapy Drugs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Targeted Chemotherapy Drugs are a class of medications designed to specifically target and attack cancer cells without affecting normal cells. They work by identifying and interfering with specific molecules involved in the growth, progression, and spread of cancer. These drugs can be considered a form of precision medicine, as they aim to match a patient’s individual genetic profile with an appropriate targeted therapy.
From a downstream perspective, Breast Cancer Treatment accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Targeted Chemotherapy Drugs leading manufacturers including Roche, Celgene, Bristol-Myers Squibb, Takeda, Seekyo, etc., dominate supply; the top five capture approximately % of global revenue, with Roche leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Targeted Chemotherapy Drugs market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Targeted Chemotherapy Drugs Market Report

Report Metric Details
Report Name Targeted Chemotherapy Drugs Market
Segment by Type
  • Monoclonal Antibodies (MABs)
  • Cancer Growth Blockers
  • Angiogenesis Inhibitors
  • PARP Inhibitors
Segment by Application
  • Breast Cancer Treatment
  • Lung Cancer Treatment
  • Gastric Cancer Treatment
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Celgene, Bristol-Myers Squibb, Takeda, Seekyo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Targeted Chemotherapy Drugs study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Targeted Chemotherapy Drugs Market report?

Ans: The main players in the Targeted Chemotherapy Drugs Market are Roche, Celgene, Bristol-Myers Squibb, Takeda, Seekyo

What are the Application segmentation covered in the Targeted Chemotherapy Drugs Market report?

Ans: The Applications covered in the Targeted Chemotherapy Drugs Market report are Breast Cancer Treatment, Lung Cancer Treatment, Gastric Cancer Treatment, Others

What are the Type segmentation covered in the Targeted Chemotherapy Drugs Market report?

Ans: The Types covered in the Targeted Chemotherapy Drugs Market report are Monoclonal Antibodies (MABs), Cancer Growth Blockers, Angiogenesis Inhibitors, PARP Inhibitors

1 Study Coverage
1.1 Introduction to Targeted Chemotherapy Drugs: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Targeted Chemotherapy Drugs Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies (MABs)
1.2.3 Cancer Growth Blockers
1.2.4 Angiogenesis Inhibitors
1.2.5 PARP Inhibitors
1.3 Market Segmentation by Application
1.3.1 Global Targeted Chemotherapy Drugs Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Breast Cancer Treatment
1.3.3 Lung Cancer Treatment
1.3.4 Gastric Cancer Treatment
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Targeted Chemotherapy Drugs Revenue Estimates and Forecasts 2020-2031
2.2 Global Targeted Chemotherapy Drugs Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Targeted Chemotherapy Drugs Sales Estimates and Forecasts 2020-2031
2.4 Global Targeted Chemotherapy Drugs Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Targeted Chemotherapy Drugs Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Targeted Chemotherapy Drugs Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Monoclonal Antibodies (MABs) Market Size by Manufacturers
3.5.2 Cancer Growth Blockers Market Size by Manufacturers
3.5.3 Angiogenesis Inhibitors Market Size by Manufacturers
3.5.4 PARP Inhibitors Market Size by Manufacturers
3.6 Global Targeted Chemotherapy Drugs Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Targeted Chemotherapy Drugs Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Targeted Chemotherapy Drugs Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Targeted Chemotherapy Drugs Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Targeted Chemotherapy Drugs Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Targeted Chemotherapy Drugs Sales and Revenue by Type (2020-2031)
6.4 North America Targeted Chemotherapy Drugs Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Targeted Chemotherapy Drugs Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Targeted Chemotherapy Drugs Sales and Revenue by Type (2020-2031)
7.4 Europe Targeted Chemotherapy Drugs Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Targeted Chemotherapy Drugs Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Targeted Chemotherapy Drugs Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Targeted Chemotherapy Drugs Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Targeted Chemotherapy Drugs Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Targeted Chemotherapy Drugs Sales and Revenue by Type (2020-2031)
9.4 Central and South America Targeted Chemotherapy Drugs Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Targeted Chemotherapy Drugs Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Targeted Chemotherapy Drugs Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Targeted Chemotherapy Drugs Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Targeted Chemotherapy Drugs Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Roche
11.1.1 Roche Corporation Information
11.1.2 Roche Business Overview
11.1.3 Roche Targeted Chemotherapy Drugs Product Models, Descriptions and Specifications
11.1.4 Roche Targeted Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Roche Targeted Chemotherapy Drugs Sales by Product in 2024
11.1.6 Roche Targeted Chemotherapy Drugs Sales by Application in 2024
11.1.7 Roche Targeted Chemotherapy Drugs Sales by Geographic Area in 2024
11.1.8 Roche Targeted Chemotherapy Drugs SWOT Analysis
11.1.9 Roche Recent Developments
11.2 Celgene
11.2.1 Celgene Corporation Information
11.2.2 Celgene Business Overview
11.2.3 Celgene Targeted Chemotherapy Drugs Product Models, Descriptions and Specifications
11.2.4 Celgene Targeted Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Celgene Targeted Chemotherapy Drugs Sales by Product in 2024
11.2.6 Celgene Targeted Chemotherapy Drugs Sales by Application in 2024
11.2.7 Celgene Targeted Chemotherapy Drugs Sales by Geographic Area in 2024
11.2.8 Celgene Targeted Chemotherapy Drugs SWOT Analysis
11.2.9 Celgene Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Corporation Information
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Targeted Chemotherapy Drugs Product Models, Descriptions and Specifications
11.3.4 Bristol-Myers Squibb Targeted Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Bristol-Myers Squibb Targeted Chemotherapy Drugs Sales by Product in 2024
11.3.6 Bristol-Myers Squibb Targeted Chemotherapy Drugs Sales by Application in 2024
11.3.7 Bristol-Myers Squibb Targeted Chemotherapy Drugs Sales by Geographic Area in 2024
11.3.8 Bristol-Myers Squibb Targeted Chemotherapy Drugs SWOT Analysis
11.3.9 Bristol-Myers Squibb Recent Developments
11.4 Takeda
11.4.1 Takeda Corporation Information
11.4.2 Takeda Business Overview
11.4.3 Takeda Targeted Chemotherapy Drugs Product Models, Descriptions and Specifications
11.4.4 Takeda Targeted Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Takeda Targeted Chemotherapy Drugs Sales by Product in 2024
11.4.6 Takeda Targeted Chemotherapy Drugs Sales by Application in 2024
11.4.7 Takeda Targeted Chemotherapy Drugs Sales by Geographic Area in 2024
11.4.8 Takeda Targeted Chemotherapy Drugs SWOT Analysis
11.4.9 Takeda Recent Developments
11.5 Seekyo
11.5.1 Seekyo Corporation Information
11.5.2 Seekyo Business Overview
11.5.3 Seekyo Targeted Chemotherapy Drugs Product Models, Descriptions and Specifications
11.5.4 Seekyo Targeted Chemotherapy Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Seekyo Targeted Chemotherapy Drugs Sales by Product in 2024
11.5.6 Seekyo Targeted Chemotherapy Drugs Sales by Application in 2024
11.5.7 Seekyo Targeted Chemotherapy Drugs Sales by Geographic Area in 2024
11.5.8 Seekyo Targeted Chemotherapy Drugs SWOT Analysis
11.5.9 Seekyo Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Targeted Chemotherapy Drugs Industry Chain
12.2 Targeted Chemotherapy Drugs Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Targeted Chemotherapy Drugs Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Targeted Chemotherapy Drugs Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Targeted Chemotherapy Drugs Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Targeted Chemotherapy Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Roche
Celgene
Bristol–Myers Squibb
Takeda
Seekyo
List of Tables
 Table 1. Global Targeted Chemotherapy Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Targeted Chemotherapy Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Targeted Chemotherapy Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Targeted Chemotherapy Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Targeted Chemotherapy Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Targeted Chemotherapy Drugs Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Targeted Chemotherapy Drugs Sales by Region (2020-2025) & (K Units)
 Table 8. Global Targeted Chemotherapy Drugs Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Targeted Chemotherapy Drugs Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Targeted Chemotherapy Drugs Sales Share by Manufacturers (2020-2025)
 Table 12. Global Targeted Chemotherapy Drugs Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Targeted Chemotherapy Drugs Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Targeted Chemotherapy Drugs by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Targeted Chemotherapy Drugs as of 2024)
 Table 16. Global Targeted Chemotherapy Drugs Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Targeted Chemotherapy Drugs Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Targeted Chemotherapy Drugs Manufacturing Base and Headquarters
 Table 19. Global Targeted Chemotherapy Drugs Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Targeted Chemotherapy Drugs Sales by Type (2020-2025) & (K Units)
 Table 23. Global Targeted Chemotherapy Drugs Sales by Type (2026-2031) & (K Units)
 Table 24. Global Targeted Chemotherapy Drugs Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Targeted Chemotherapy Drugs Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Targeted Chemotherapy Drugs ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Targeted Chemotherapy Drugs Sales by Application (2020-2025) & (K Units)
 Table 29. Global Targeted Chemotherapy Drugs Sales by Application (2026-2031) & (K Units)
 Table 30. Targeted Chemotherapy Drugs High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Targeted Chemotherapy Drugs Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Targeted Chemotherapy Drugs Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Targeted Chemotherapy Drugs ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Targeted Chemotherapy Drugs Growth Accelerators and Market Barriers
 Table 37. North America Targeted Chemotherapy Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Targeted Chemotherapy Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Targeted Chemotherapy Drugs Growth Accelerators and Market Barriers
 Table 40. Europe Targeted Chemotherapy Drugs Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Targeted Chemotherapy Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Targeted Chemotherapy Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Targeted Chemotherapy Drugs Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Targeted Chemotherapy Drugs Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Targeted Chemotherapy Drugs Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Targeted Chemotherapy Drugs Investment Opportunities and Key Challenges
 Table 47. Central and South America Targeted Chemotherapy Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Targeted Chemotherapy Drugs Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Targeted Chemotherapy Drugs Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Roche Corporation Information
 Table 51. Roche Description and Major Businesses
 Table 52. Roche Product Models, Descriptions and Specifications
 Table 53. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Roche Sales Value Proportion by Product in 2024
 Table 55. Roche Sales Value Proportion by Application in 2024
 Table 56. Roche Sales Value Proportion by Geographic Area in 2024
 Table 57. Roche Targeted Chemotherapy Drugs SWOT Analysis
 Table 58. Roche Recent Developments
 Table 59. Celgene Corporation Information
 Table 60. Celgene Description and Major Businesses
 Table 61. Celgene Product Models, Descriptions and Specifications
 Table 62. Celgene Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Celgene Sales Value Proportion by Product in 2024
 Table 64. Celgene Sales Value Proportion by Application in 2024
 Table 65. Celgene Sales Value Proportion by Geographic Area in 2024
 Table 66. Celgene Targeted Chemotherapy Drugs SWOT Analysis
 Table 67. Celgene Recent Developments
 Table 68. Bristol-Myers Squibb Corporation Information
 Table 69. Bristol-Myers Squibb Description and Major Businesses
 Table 70. Bristol-Myers Squibb Product Models, Descriptions and Specifications
 Table 71. Bristol-Myers Squibb Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Bristol-Myers Squibb Sales Value Proportion by Product in 2024
 Table 73. Bristol-Myers Squibb Sales Value Proportion by Application in 2024
 Table 74. Bristol-Myers Squibb Sales Value Proportion by Geographic Area in 2024
 Table 75. Bristol-Myers Squibb Targeted Chemotherapy Drugs SWOT Analysis
 Table 76. Bristol-Myers Squibb Recent Developments
 Table 77. Takeda Corporation Information
 Table 78. Takeda Description and Major Businesses
 Table 79. Takeda Product Models, Descriptions and Specifications
 Table 80. Takeda Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Takeda Sales Value Proportion by Product in 2024
 Table 82. Takeda Sales Value Proportion by Application in 2024
 Table 83. Takeda Sales Value Proportion by Geographic Area in 2024
 Table 84. Takeda Targeted Chemotherapy Drugs SWOT Analysis
 Table 85. Takeda Recent Developments
 Table 86. Seekyo Corporation Information
 Table 87. Seekyo Description and Major Businesses
 Table 88. Seekyo Product Models, Descriptions and Specifications
 Table 89. Seekyo Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Seekyo Sales Value Proportion by Product in 2024
 Table 91. Seekyo Sales Value Proportion by Application in 2024
 Table 92. Seekyo Sales Value Proportion by Geographic Area in 2024
 Table 93. Seekyo Targeted Chemotherapy Drugs SWOT Analysis
 Table 94. Seekyo Recent Developments
 Table 95. Key Raw Materials Distribution
 Table 96. Raw Materials Key Suppliers
 Table 97. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 98. Milestones in Production Technology Evolution
 Table 99. Distributors List
 Table 100. Market Trends and Market Evolution
 Table 101. Market Drivers and Opportunities
 Table 102. Market Challenges, Risks, and Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources


List of Figures
 Figure 1. Targeted Chemotherapy Drugs Product Picture
 Figure 2. Global Targeted Chemotherapy Drugs Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Monoclonal Antibodies (MABs) Product Picture
 Figure 4. Cancer Growth Blockers Product Picture
 Figure 5. Angiogenesis Inhibitors Product Picture
 Figure 6. PARP Inhibitors Product Picture
 Figure 7. Global Targeted Chemotherapy Drugs Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Breast Cancer Treatment
 Figure 9. Lung Cancer Treatment
 Figure 10. Gastric Cancer Treatment
 Figure 11. Others
 Figure 12. Targeted Chemotherapy Drugs Report Years Considered
 Figure 13. Global Targeted Chemotherapy Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Targeted Chemotherapy Drugs Revenue (2020-2031) & (US$ Million)
 Figure 15. Global Targeted Chemotherapy Drugs Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 16. Global Targeted Chemotherapy Drugs Revenue Market Share by Region (2020-2031)
 Figure 17. Global Targeted Chemotherapy Drugs Sales (2020-2031) & (K Units)
 Figure 18. Global Targeted Chemotherapy Drugs Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 19. Global Targeted Chemotherapy Drugs Sales Market Share by Region (2020-2031)
 Figure 20. Top 5 and Top 10 Manufacturers Targeted Chemotherapy Drugs Sales Volume Market Share in 2024
 Figure 21. Global Targeted Chemotherapy Drugs Revenue Market Share Ranking (2024)
 Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 23. Monoclonal Antibodies (MABs) Revenue Market Share by Manufacturer in 2024
 Figure 24. Cancer Growth Blockers Revenue Market Share by Manufacturer in 2024
 Figure 25. Angiogenesis Inhibitors Revenue Market Share by Manufacturer in 2024
 Figure 26. PARP Inhibitors Revenue Market Share by Manufacturer in 2024
 Figure 27. Global Targeted Chemotherapy Drugs Sales Market Share by Type (2020-2031)
 Figure 28. Global Targeted Chemotherapy Drugs Revenue Market Share by Type (2020-2031)
 Figure 29. Global Targeted Chemotherapy Drugs Sales Market Share by Application (2020-2031)
 Figure 30. Global Targeted Chemotherapy Drugs Revenue Market Share by Application (2020-2031)
 Figure 31. North America Targeted Chemotherapy Drugs Sales YoY (2020-2031) & (K Units)
 Figure 32. North America Targeted Chemotherapy Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 33. North America Top 5 Manufacturers Targeted Chemotherapy Drugs Sales Revenue (US$ Million) in 2024
 Figure 34. North America Targeted Chemotherapy Drugs Sales Volume (K Units) by Type (2020- 2031)
 Figure 35. North America Targeted Chemotherapy Drugs Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 36. North America Targeted Chemotherapy Drugs Sales Volume (K Units) by Application (2020-2031)
 Figure 37. North America Targeted Chemotherapy Drugs Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 38. US Targeted Chemotherapy Drugs Revenue (2020-2031) & (US$ Million)
 Figure 39. Canada Targeted Chemotherapy Drugs Revenue (2020-2031) & (US$ Million)
 Figure 40. Mexico Targeted Chemotherapy Drugs Revenue (2020-2031) & (US$ Million)
 Figure 41. Europe Targeted Chemotherapy Drugs Sales YoY (2020-2031) & (K Units)
 Figure 42. Europe Targeted Chemotherapy Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 43. Europe Top 5 Manufacturers Targeted Chemotherapy Drugs Sales Revenue (US$ Million) in 2024
 Figure 44. Europe Targeted Chemotherapy Drugs Sales Volume (K Units) by Type (2020-2031)
 Figure 45. Europe Targeted Chemotherapy Drugs Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 46. Europe Targeted Chemotherapy Drugs Sales Volume (K Units) by Application (2020-2031)
 Figure 47. Europe Targeted Chemotherapy Drugs Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 48. Germany Targeted Chemotherapy Drugs Revenue (2020-2031) & (US$ Million)
 Figure 49. France Targeted Chemotherapy Drugs Revenue (2020-2031) & (US$ Million)
 Figure 50. U.K. Targeted Chemotherapy Drugs Revenue (2020-2031) & (US$ Million)
 Figure 51. Italy Targeted Chemotherapy Drugs Revenue (2020-2031) & (US$ Million)
 Figure 52. Russia Targeted Chemotherapy Drugs Revenue (2020-2031) & (US$ Million)
 Figure 53. Asia-Pacific Targeted Chemotherapy Drugs Sales YoY (2020-2031) & (K Units)
 Figure 54. Asia-Pacific Targeted Chemotherapy Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 55. Asia-Pacific Top 8 Manufacturers Targeted Chemotherapy Drugs Sales Revenue (US$ Million) in 2024
 Figure 56. Asia-Pacific Targeted Chemotherapy Drugs Sales Volume (K Units) by Type (2020- 2031)
 Figure 57. Asia-Pacific Targeted Chemotherapy Drugs Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 58. Asia-Pacific Targeted Chemotherapy Drugs Sales Volume (K Units) by Application (2020-2031)
 Figure 59. Asia-Pacific Targeted Chemotherapy Drugs Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 60. Indonesia Targeted Chemotherapy Drugs Revenue (2020-2031) & (US$ Million)
 Figure 61. Japan Targeted Chemotherapy Drugs Revenue (2020-2031) & (US$ Million)
 Figure 62. South Korea Targeted Chemotherapy Drugs Revenue (2020-2031) & (US$ Million)
 Figure 63. China Taiwan Targeted Chemotherapy Drugs Revenue (2020-2031) & (US$ Million)
 Figure 64. India Targeted Chemotherapy Drugs Revenue (2020-2031) & (US$ Million)
 Figure 65. Central and South America Targeted Chemotherapy Drugs Sales YoY (2020-2031) & (K Units)
 Figure 66. Central and South America Targeted Chemotherapy Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 67. Central and South America Top 5 Manufacturers Targeted Chemotherapy Drugs Sales Revenue (US$ Million) in 2024
 Figure 68. Central and South America Targeted Chemotherapy Drugs Sales Volume (K Units) by Type (2021-2031)
 Figure 69. Central and South America Targeted Chemotherapy Drugs Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 70. Central and South America Targeted Chemotherapy Drugs Sales Volume (K Units) by Application (2020-2031)
 Figure 71. Central and South America Targeted Chemotherapy Drugs Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 72. Brazil Targeted Chemotherapy Drugs Revenue (2020-2025) & (US$ Million)
 Figure 73. Argentina Targeted Chemotherapy Drugs Revenue (2020-2025) & (US$ Million)
 Figure 74. Middle East, and Africa Targeted Chemotherapy Drugs Sales YoY (2020-2031) & (K Units)
 Figure 75. Middle East and Africa Targeted Chemotherapy Drugs Revenue YoY (2020-2031) & (US$ Million)
 Figure 76. Middle East and Africa Top 5 Manufacturers Targeted Chemotherapy Drugs Sales Revenue (US$ Million) in 2024
 Figure 77. Middle East and Africa Targeted Chemotherapy Drugs Sales Volume (K Units) by Type (2021-2031)
 Figure 78. South America Targeted Chemotherapy Drugs Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 79. Middle East and Africa Targeted Chemotherapy Drugs Sales Volume (K Units) by Application (2020-2031)
 Figure 80. Middle East and Africa Targeted Chemotherapy Drugs Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 81. GCC Countries Targeted Chemotherapy Drugs Revenue (2020-2025) & (US$ Million)
 Figure 82. Turkey Targeted Chemotherapy Drugs Revenue (2020-2025) & (US$ Million)
 Figure 83. Egypt Targeted Chemotherapy Drugs Revenue (2020-2025) & (US$ Million)
 Figure 84. South Africa Targeted Chemotherapy Drugs Revenue (2020-2025) & (US$ Million)
 Figure 85. Targeted Chemotherapy Drugs Industry Chain Mapping
 Figure 86. Regional Targeted Chemotherapy Drugs Manufacturing Base Distribution (%)
 Figure 87. Global Targeted Chemotherapy Drugs Production Market Share by Region (2020-2031)
 Figure 88. Targeted Chemotherapy Drugs Production Process
 Figure 89. Regional Targeted Chemotherapy Drugs Production Cost Structure
 Figure 90. Channels of Distribution (Direct Vs Distribution)
 Figure 91. Bottom-up and Top-down Approaches for This Report
 Figure 92. Data Triangulation
 Figure 93. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Targeted Oncology Drugs Market Research Report 2024
Global Cancer Targeted Drug Market Research Report 2025
Global Targeted Cancer Therapy Market Research Report 2024
Global Targeted Small Molecule Drug Market Research Report 2025
Global Personalized Cancer Medicine Market Research Report 2025
Global Cancer Targeted Small Molecule Therapy Market Research Report 2025
Global Targeted Small Molecule Therapy Market Research Report 2025
Global Anticancer Drugs Market Research Report 2025
Global Precision Cancer Medicine Market Research Report 2024
Global Oncology Targeted Therapy Market Research Report 2025
Global Targeted Antitumor Drugs Market Research Report 2025
Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030
Global Chemotherapy Drug Market Insights Forecast to 2030
Global Targeted Radiotherapy Drug Market Research Report 2024
Global Leukemia Targeted Therapy Drugs Market Research Report 2024
Cancer Treatment Drugs Market
Global Oncology Injection Drug Market Research Report 2025
Global Small Molecule Targeted Cancer Therapy Market Research Report 2025
Molecular Targeted Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions